Is Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) CEO Paid At A Competitive Rate?HomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Is Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) CEO Paid At A Competitive Rate?Simply Wall StSimply Wall St.January 6, 2020ReblogShareTweetShareView photosShaojun Chen became the CEO of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) in 2016. First, this article will compare CEO compensation with compensation at similar sized companies. After that, we will consider the growth in the business. And finally we will reflect on how common stockholders have fared in the last few years, as a secondary measure of performance. This method should give us information to assess how appropriately the company pays the CEO. View our latest analysis for Dawnrays Pharmaceutical (Holdings) How Does Shaojun Chen's Compensation Compare With Similar Sized Companies?At the time of writing, our data says that Dawnrays Pharmaceutical (Holdings) Limited has a market cap of HK$2.2b, and reported total annual CEO compensation of CN¥5.5m for the year to December 2018. We think total compensation is more important but we note that the CEO salary is lower, at CN¥1.5m. We note that more than half of the total compensation is not the salary; and performance requirements may apply to this non-salary portion. We examined companies with market caps from CN¥697m to CN¥2.8b, and discovered that the median CEO total compensation of that group was CN¥2.1m.Thus we can conclude that Shaojun Chen receives more in total compensation than the median of a group of companies in the same market, and of similar size to Dawnrays Pharmaceutical (Holdings) Limited. However, this doesn't necessarily mean the pay is too high. We can better assess whether the pay is overly generous by looking into the underlying business performance.The graphic below shows how CEO compensation at Dawnrays Pharmaceutical (Holdings) has changed from year to year.SEHK:2348 CEO Compensation, January 6th 2020MoreIs Dawnrays Pharmaceutical (Holdings) Limited Growing?Over the last three years Dawnrays Pharmaceutical (Holdings) Limited has grown its earnings per share (EPS) by an average of 4.2% per year (using a line of best fit). Revenue was pretty flat on last year.I would argue that the lack of revenue growth in the last year is less than ideal, but I'm happy with the EPS growth. In conclusion we can't form a strong opinion about business performance yet; but it's one worth watching. Although we don't have analyst forecasts shareholders might want to examine this detailed historical graph of earnings, revenue and cash flow.Has Dawnrays Pharmaceutical (Holdings) Limited Been A Good Investment?With a three year total loss of 28%, Dawnrays Pharmaceutical (Holdings) Limited would certainly have some dissatisfied shareholders. This suggests it would be unwise for the company to pay the CEO too generously.In Summary...We compared the total CEO remuneration paid by Dawnrays Pharmaceutical (Holdings) Limited, and compared it to remuneration at a group of similar sized companies. We found that it pays well over the median amount paid in the benchmark group.Over the last three years, shareholder returns have been downright disappointing, and the underlying business has failed to impress us. Considering this, we have the opinion that the CEO pay is more on the generous side, than the modest side. If you think CEO compensation levels are interesting you will probably really like this free visualization of insider trading at Dawnrays Pharmaceutical (Holdings).Arguably, business quality is much more important than CEO compensation levels. So check out this free list of interesting companies, that have HIGH return on equity and low debt.Story continuesIf you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextThis stock has scored the biggest boost from the coronavirus outbreak — but the company has been out of business for yearsMarketWatchHere's What We Think About Carrianna Group Holdings Company Limited's (HKG:126) CEO PaySimply Wall St.Top Marijuana Stocks for March 2020InvestopediaRE/MAX Holdings, Inc. (NYSE:RMAX) Is About To Go Ex-Dividend, And It Pays A 2.8% YieldSimply Wall St.Wagners Holding Company Limited Reported A Surprise Loss, And Analysts Have Updated Their ForecastsSimply Wall St.Richard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoInvestors ditch market risk as stocks fall into correctionReutersStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceMost face masks won’t protect you from the coronavirusYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance Video